logo
Select company
Select metric
Ticker Information

Ticker

XNCR

Company Name

XENCOR INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

XENCOR INC - Price to Earnings Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

XNCR - P/E Historical data
DateMarket CapitalizationNet Income Common StockPrice to Earnings
6/30/2025$ 534.21M$ -171.08M0
3/31/2025$ 568.3M$ -207.6M0
12/31/2024$ 1.06B$ -232.62M0
9/30/2024$ 1.59B$ -198.24M0
6/30/2024$ 1.1B$ -177.37M0
3/31/2024$ 1.45B$ -133.36M0
12/31/2023$ 1.4B$ -126.09M0
9/30/2023$ 1.05B$ -119.03M0
6/30/2023$ 1.42B$ -127.52M0
3/31/2023$ 1.65B$ -139.54M0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • XENCOR INC's latest trailing twelve months (TTM) P/E stands at 0.
  • Over the past 5 years, XENCOR INC's average P/E has been 49.28.
  • The median P/E for XENCOR INC during this period was 53.99
  • XENCOR INC reached its highest P/E over the past 5 years at 78.5.
  • The lowest P/E recorded by XENCOR INC in the same timeframe 13.56

XENCOR INC's P/E vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

P/E Benchmarks
CompanyP/E
RGNX : REGENXBIO INC -ANAB : ANAPTYSBIO INC -CTMX : CYTOMX THERAPEUTICS INC 7.22KURA : KURA ONCOLOGY INC -PHAT : PHATHOM PHARMACEUTICALS INC -MRVI : MARAVAI LIFESCIENCES HOLDINGS INC -SAGE : SAGE THERAPEUTICS INC -GYRE : GYRE THERAPEUTICS INC 163.03ARCT : ARCTURUS THERAPEUTICS HOLDINGS INC -DAWN : DAY ONE BIOPHARMACEUTICALS INC -

Definition of Price to Earnings

[Calculation] Measures a company’s [MarketCap] in relation to its Net Income [NetIncCmn]. A high P/E ratio indicates that investors anticipate greater future earnings growth compared to companies with a lower P/E.
Market Cap / Net Inc. Cmn.
(=) P/E
P/E for XENCOR INC is calculated as follows: Market Cap [ $ 2.18B ] / Net Inc. Cmn. [ $ -82.55M ]
(=) P/E [ 0 ]

XNCR - Price to Earnings, Last 5 years

13.56

Minimum

Mar 31, 2022

78.5

Maximum

Jun 30, 2022

49.28

Average

53.99

Median

P/E Benchmark Analysis

The chart above depicts the distribution of P/E for companies in the Total Stock Market. The average P/E of the companies is 22.52 with a standard deviation of 13.96.
The following table provides additional summary stats:
P/E in the Market:
filtered constituents2.08K
min0.13
max70.11
average22.52
median18.89
std13.96